online digital currency exchange- Top People also ask

President of Hilton Asia Pacific: India's outbound travel will be the story of the next decade. According to the data of the World Tourism and Travel Council, in 2023, Indian tourists spent $34.2 billion on outbound travel. Allen Watts, president of Hilton Asia Pacific, said that compared with the future, the current level of Indian outbound travel consumption is "negligible". "The story of India is unfolding before us," he said. "India's outbound travel will be the story of the next decade." According to the World Tourism and Travel Council's Economic Impact in 2024 report, by 2034, the outbound spending of Indian tourists is expected to more than double, reaching 76.8 billion US dollars, which will make India's position in the global tourism consumption country rise from the 12th in 2023 to the 7th.Adobe's US stocks fell about 9% before the market, and the company's annual performance guidance was worse than expected.After the emergency martial law storm, South Korea's financial industry suffered successively. After the emergency martial law storm in South Korea, South Korea's financial industry suffered successively, and the stock market fluctuated obviously. This week, it began to rebound slightly. South Korean media pointed out that the uncertainty of South Korea's political situation may put its international reputation under downward pressure. South Korea's Deputy Prime Minister and Minister of Planning and Finance, Choe Sang-mu, held an "emergency macroeconomic and financial symposium" on the 10th to discuss the dynamics of the financial and foreign exchange markets and the countermeasures. According to South Korea's Chosun Ilbo reported on the 9th, after the emergency martial law storm, the total market value of South Korea's stock market evaporated by 58 trillion won within three days, and more than 400 billion US dollars of foreign exchange reserves were also threatened. As the political struggle of "impeaching the president" continues, not only finance, but also retail, alcohol, real estate, semiconductor export and other aspects of the Korean economy have also felt the chill. South Korean media believe that if financial instability and the stagnation of the real economy, the economy may fall into crisis sharply. According to the "Foreign Securities Investment Trends in November" released by the Korea Financial Supervisory Authority on the 10th, foreign investors sold 4.154 trillion won in the Korean securities market last month and sold Korean shares for four consecutive months. South Korea's "Asia Daily" said on the 10th that as South Korea re-entered the presidential impeachment time, the uncertainty intensified, and it is expected that the net selling behavior of foreign investors will continue. Although South Korea's stock market rebounded on the 10th, the uncertainty of the political situation put its international reputation under downward pressure. South Korea's Chosun Ilbo published a commentary on the 10th, saying that Fitch and Moody's, among the world's three major credit rating agencies, have successively warned that if the storm after martial law is prolonged, South Korea's national credit rating may be negatively affected. (CCTV)

In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for generic drug substitution. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)South Korea's National Assembly passed "Yin Xiyue's General Special Inspection Law" and "Jin Jianxit's Inspection Law". The reporter of the General Station was informed that on the 12th local time, South Korea's National Assembly held a general meeting of parliamentarians and passed "Yin Xiyue's General Special Inspection Law" and "Jin Jianxit's Inspection Law". (CCTV News)Botuo Bio: Adjust the profit distribution plan for the first three quarters of 2024. Botuo Bio announced that the total amount of cash dividends to be distributed in the company's profit distribution for the first three quarters of 2024 was adjusted from RMB 52.2583 million to RMB 53.2083 million. Before the adjustment, the company's total share capital was 105 million shares after deducting the shares in the company's repurchase special securities account, and a total cash dividend of 52.2583 million yuan was planned to be distributed. After adjustment, the company's total share capital is 107 million shares, of which 250,000 shares are repurchased in the special securities account, and the total number of shares actually participating in the profit distribution of the company is 106 million shares, with a total cash dividend of 53,208,300 yuan.

The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.Turkish Defense Ministry source: Syrian allies continue to advance in northern Syria to "eliminate terrorism".Qianjin Pharmaceutical Co., Ltd.: The subsidiary company obtained the dapoxetine hydrochloride Pharmaceutical Registration Certificate, and Qianjin Pharmaceutical announced that Qianjin Xiangjiang Pharmaceutical Co., Ltd. received the dapoxetine hydrochloride Pharmaceutical Registration Certificate approved and issued by National Medical Products Administration. The medicine is suitable for the treatment of male premature ejaculation patients aged 18 to 64.